Brian Salmons
Directeur Général chez Austrianova Singapore Pvt Ltd.
Profil
Brian Salmons has held the following positions in his career: Chief Executive Officer at Austrianova Singapore Pvt Ltd.
since 2015, and Development Advisor at Sentinext Therapeutics Sdn.
Bhd.
Postes actifs de Brian Salmons
| Sociétés | Poste | Début |
|---|---|---|
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Corporate Officer/Principal | - |
Austrianova Singapore Pvt Ltd.
 Austrianova Singapore Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of PharmaCyte Biotech, Inc., Austrianova Singapore Pvt Ltd. is a Singaporean company that researches, develops, and produces live-cell encapsulation technologies for medical treatment. The company was founded by Walter H. Günzburgs. Brian Salmons has been the CEO of the company since 2015. | Directeur Général | 10/02/2015 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
Austrianova Singapore Pvt Ltd.
Austrianova Singapore Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of PharmaCyte Biotech, Inc., Austrianova Singapore Pvt Ltd. is a Singaporean company that researches, develops, and produces live-cell encapsulation technologies for medical treatment. The company was founded by Walter H. Günzburgs. Brian Salmons has been the CEO of the company since 2015. | Commercial Services |
